View in EDS

Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).

Saved in:
Bibliographic Details
Title: Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
Authors: Drakaki A; Division of Hematology and Oncology, UCLA David Geffen School of Medicine, Los Angeles, California., Powles T; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, United Kingdom., Bamias A; National and Kapodistrian University of Athens, Athens, Greece., Martin-Liberal J; Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain., Shin SJ; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., Friedlander T; University of California San Francisco, Helen Diller Family Cancer Center, San Francisco, California., Tosi D; Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Park C; Norton Cancer Institute, Louisville, Kentucky., Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud/IUCT Oncopole, Toulouse, France., Joly Lobbedez F; Centre Francois-Baclesse, Medical Oncology, Caen, France., Castellano D; Hospital 12 de Octubre, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno-Candilejo I; START Madrid Phase I Unit, Hospital Sanchinarro, Madrid, Spain., Fléchon A; Centre Léon Bérard, Lyon, France., Yuen K; Genentech, Inc., South San Francisco, California., Rishipathak D; Genentech, Inc., South San Francisco, California., DuPree K; Genentech, Inc., South San Francisco, California., Young F; Roche Products Ltd, Welwyn Garden City, United Kingdom., Michielin F; Roche Innovation Center Basel, Basel, Switzerland., Shemesh CS; Genentech, Inc., South San Francisco, California., Steinberg EE; Genentech, Inc., South San Francisco, California., Williams P; Genentech, Inc., South San Francisco, California., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 01; Vol. 29 (21), pp. 4373-4384.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37651261
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Drakaki+A%22">Drakaki A</searchLink>; Division of Hematology and Oncology, UCLA David Geffen School of Medicine, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Powles+T%22">Powles T</searchLink>; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bamias+A%22">Bamias A</searchLink>; National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Martin-Liberal+J%22">Martin-Liberal J</searchLink>; Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Shin+SJ%22">Shin SJ</searchLink>; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Friedlander+T%22">Friedlander T</searchLink>; University of California San Francisco, Helen Diller Family Cancer Center, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Tosi+D%22">Tosi D</searchLink>; Institut régional du Cancer de Montpellier (ICM), Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Park+C%22">Park C</searchLink>; Norton Cancer Institute, Louisville, Kentucky.<br /><searchLink fieldCode="AU" term="%22Gomez-Roca+C%22">Gomez-Roca C</searchLink>; Department of Medical Oncology, Institut Claudius Regaud/IUCT Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Joly+Lobbedez+F%22">Joly Lobbedez F</searchLink>; Centre Francois-Baclesse, Medical Oncology, Caen, France.<br /><searchLink fieldCode="AU" term="%22Castellano+D%22">Castellano D</searchLink>; Hospital 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Morales-Barrera+R%22">Morales-Barrera R</searchLink>; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno-Candilejo+I%22">Moreno-Candilejo I</searchLink>; START Madrid Phase I Unit, Hospital Sanchinarro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fléchon+A%22">Fléchon A</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Yuen+K%22">Yuen K</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rishipathak+D%22">Rishipathak D</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22DuPree+K%22">DuPree K</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Young+F%22">Young F</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Michielin+F%22">Michielin F</searchLink>; Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Steinberg+EE%22">Steinberg EE</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Williams+P%22">Williams P</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Lee+JL%22">Lee JL</searchLink>; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2023 Nov 01; Vol. 29 (21), pp. 4373-4384.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37651261
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-23-0798
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4373
    Titles:
      – TitleFull: Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Drakaki A
      – PersonEntity:
          Name:
            NameFull: Powles T
      – PersonEntity:
          Name:
            NameFull: Bamias A
      – PersonEntity:
          Name:
            NameFull: Martin-Liberal J
      – PersonEntity:
          Name:
            NameFull: Shin SJ
      – PersonEntity:
          Name:
            NameFull: Friedlander T
      – PersonEntity:
          Name:
            NameFull: Tosi D
      – PersonEntity:
          Name:
            NameFull: Park C
      – PersonEntity:
          Name:
            NameFull: Gomez-Roca C
      – PersonEntity:
          Name:
            NameFull: Joly Lobbedez F
      – PersonEntity:
          Name:
            NameFull: Castellano D
      – PersonEntity:
          Name:
            NameFull: Morales-Barrera R
      – PersonEntity:
          Name:
            NameFull: Moreno-Candilejo I
      – PersonEntity:
          Name:
            NameFull: Fléchon A
      – PersonEntity:
          Name:
            NameFull: Yuen K
      – PersonEntity:
          Name:
            NameFull: Rishipathak D
      – PersonEntity:
          Name:
            NameFull: DuPree K
      – PersonEntity:
          Name:
            NameFull: Young F
      – PersonEntity:
          Name:
            NameFull: Michielin F
      – PersonEntity:
          Name:
            NameFull: Shemesh CS
      – PersonEntity:
          Name:
            NameFull: Steinberg EE
      – PersonEntity:
          Name:
            NameFull: Williams P
      – PersonEntity:
          Name:
            NameFull: Lee JL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 21
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1